Public ID: PID-GYLMEB

Clear categories and streamlined procedures introduced for modifying pharmaceutical registries in Uruguay

in Uruguay

Trade barrier summary

UK pharmaceutical companies in Uruguay previously faced delays because of a lack of processes to efficiently update details on registers of medicines. Even minor updates, such as to a company’s address, required lengthy approval processes, which also caused delays to other approvals.

The issue was addressed following the approval of Ordinance No. 190/025, which has been implemented accurately and swiftly by Uruguay’s Ministry of Health. It has introduced clear categories and streamlined procedures, significantly improving efficiency and predictability for UK businesses operating in the market.

---

Sectors affected

• Pharmaceuticals and biotechnology

---

Resolved

Yes - November 2025

---

Date reported

22 December 2022

---

Last updated

15 January 2026

---

Public ID

PID-GYLMEB

---

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.